Telomere length varies by DNA extraction method: implications for epidemiologic research
- PMID: 24019396
- PMCID: PMC3827976
- DOI: 10.1158/1055-9965.EPI-13-0409
Telomere length varies by DNA extraction method: implications for epidemiologic research
Abstract
Background: Both shorter and longer telomeres in peripheral blood leukocyte (PBL) DNA have been associated with cancer risk. However, associations remain inconsistent across studies of the same cancer type. This study compares DNA preparation methods to determine telomere length from patients with colorectal cancer.
Methods: We examined PBL relative telomere length (RTL) measured by quantitative PCR (qPCR) in 1,033 patients with colorectal cancer and 2,952 healthy controls. DNA was extracted with phenol/chloroform, PureGene, or QIAamp.
Results: We observed differences in RTL depending on DNA extraction method (P < 0.001). Phenol/chloroform-extracted DNA had a mean RTL (T/S ratio) of 0.78 (range 0.01-6.54) compared with PureGene-extracted DNA (mean RTL of 0.75; range 0.00-12.33). DNA extracted by QIAamp yielded a mean RTL of 0.38 (range 0.02-3.69). We subsequently compared RTL measured by qPCR from an independent set of 20 colorectal cancer cases and 24 normal controls in PBL DNA extracted by each of the three extraction methods. The range of RTL measured by qPCR from QIAamp-extracted DNA (0.17-0.58) was less than from either PureGene or phenol/chloroform (ranges, 0.04-2.67 and 0.32-2.81, respectively).
Conclusions: RTL measured by qPCR from QIAamp-extracted DNA was less than from either PureGene or phenol/chloroform (P < 0.001).
Impact: Differences in DNA extraction method may contribute to the discrepancies between studies seeking to find an association between the risk of cancer or other diseases and RTL.
©2013 AACR.
Figures


Comment in
-
Telomere length varies by DNA extraction method: implications for epidemiologic research--response.Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1131. doi: 10.1158/1055-9965.EPI-14-0234. Epub 2014 May 5. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24798728 Free PMC article. No abstract available.
-
Telomere length varies by DNA extraction method: implications for epidemiologic research-letter.Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1129-30. doi: 10.1158/1055-9965.EPI-14-0145. Epub 2014 May 5. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 24798729 Free PMC article. No abstract available.
References
-
- Aviv A. Telomeres, sex, reactive oxygen species, and human cardiovascular aging. J Mol Med (Berl) 2002;80:689–95. - PubMed
-
- Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263–71. - PubMed
-
- McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev. 2007;16:815–9. - PubMed
-
- Wu G, Jiang X, Lee WH, Chen PL. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen Breakage Syndrome 1. Cancer Res. 2003;63:2589–95. - PubMed
-
- Gramatges MM, Telli ML, Balise R, Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev. 2010;19:605–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA132718/CA/NCI NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- P30 CA014520/CA/NCI NIH HHS/United States
- U24 CA074794/CA/NCI NIH HHS/United States
- P50 CA102701/CA/NCI NIH HHS/United States
- R0-1 CA132718/CA/NCI NIH HHS/United States
- P20 CA102701/CA/NCI NIH HHS/United States
- UM1 CA167551/CA/NCI NIH HHS/United States
- P30 DK084567/DK/NIDDK NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
- U01 CA074799/CA/NCI NIH HHS/United States
- CA-96-011/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- P30DK084567/DK/NIDDK NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- T35 HL007690/HL/NHLBI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources